News Conference News EACTS 2021 TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb Shelley Wood October 20, 2021
News Conference News TCT 2021 Fracture Improves Gradients in ViV TAVI, but Ideal Timing Still Unknown Michael O'Riordan October 07, 2021
News Conference News ESC 2021 PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves Yael L. Maxwell September 02, 2021
News Conference News ESC 2021 2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care Shelley Wood August 31, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News TVT 2021 Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’ Todd Neale July 23, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Conference News EuroPCR 2021 Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI Yael L. Maxwell May 19, 2021
News Conference News ACC 2021 Wide Variation in TAVI Readmission Rates Among US Hospitals L.A. McKeown May 07, 2021
News Conference News CRT 2021 LRT Trial Data Bolster Support for TAVI in Bicuspid Valves L.A. McKeown March 11, 2021
News Conference News TCT 2020 While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry L.A. McKeown October 21, 2020
News Conference News TCT 2020 Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves Todd Neale October 17, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News EuroPCR 2020 Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR L.A. McKeown July 01, 2020
News Conference News TVT 2020 Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear Todd Neale June 25, 2020
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
News Conference News TVT 2020 Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes L.A. McKeown June 19, 2020
News Conference News ACC 2020 PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients Yael L. Maxwell March 29, 2020